跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 368 条关于
“ReCava”
全部
368
临床试验
300
药物
7
机构
7
资讯
54
去年
T45 Labs Secures Oversubscribed $25M Fund to Advance Cardiovascular Medical Devices
去年
Dermatology Advances: Approvals, Trial Results, and New Guidelines Emerge
去年
Reviva Pharmaceuticals Reports Promising Preliminary OLE Data for Brilaroxazine
去年
Nationwide Recall: Unapproved EPINEPHrine Nasal Solution Raises Safety Concerns
去年
Reviva Presents Positive Brilaroxazine Data on Speech Latency in Schizophrenia from Phase 3 RECOVER Trial
10个月前
Reviva Secures European Patent for Brilaroxazine in Pulmonary Fibrosis Treatment
去年
Reviva Pharmaceuticals' Brilaroxazine Shows Positive Phase 3 Results for Schizophrenia Treatment
去年
FDA Warns Against BioZorb Markers Following Recall Due to Adverse Events
去年
Glenmark Pharmaceuticals Initiates Major Recall of ADHD Medication in US Market
去年
FDA Approved Renata Minima Stent for Infants with Congenital Heart Defects
第 1 页,共 6 页
上一页
下一页